目前,感染引发的脓毒症仍然是造成死亡和残疾的主导因素。Aird等的研究表明,血管内皮生长因子(VEGF)似乎在脓毒症的发病过程中起关键作用,可能是干预治疗的潜在新靶标。脓毒症治疗药物研究的主要难题是炎性介质间的相互影响非常复杂,且研究甚少。最近的研究中Aird等指出严重的 Currently, infection-induced sepsis remains the dominant cause of death and disability. Aird et al.’s study showed that vascular endothelial growth factor (VEGF) appears to play a pivotal role in the pathogenesis of sepsis and may be a potential new target for intervention therapy. The main challenge in sepsis drug research is that the interaction between inflammatory mediators is complex and rarely studied. Aird et al. Pointed out severe in recent research